# Study of Photobiomodulation to Treat Dry Age-Related Macular Degeneration (LIGHTSITEIIIB)

> **NCT06229665** · PHASE2,PHASE3 · UNKNOWN · sponsor: **LumiThera, Inc.** · enrollment: 75 (estimated)

## Conditions studied

- Dry Age-related Macular Degeneration

## Interventions

- **DEVICE:** Valeda Light Delivery System

## Key facts

- **NCT ID:** NCT06229665
- **Lead sponsor:** LumiThera, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-10-25
- **Primary completion:** 2025-05-01
- **Final completion:** 2025-06-01
- **Target enrollment:** 75 (ESTIMATED)
- **Last updated:** 2024-07-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06229665

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06229665, "Study of Photobiomodulation to Treat Dry Age-Related Macular Degeneration (LIGHTSITEIIIB)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06229665. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*